| |
The Controversy Of Increased Spending For Antidepressants
Thomas W. Croghan
| The first 100 words of the full text of this article appear below. |
Most of the past decade has been characterized by moderating growth in health care spending, enough so that health insurance premiums paid by employers declined between 1997 and 1998.1 Analysts have traced this moderation in spending growth to the rise of various forms of managed care, a mechanism that mitigates incentives for overuse of health care services through capitation payment, utilization controls, and contracts for discounted services.2 In the early 1990s many believed that the "managed care effect" would also apply to pharmaceuticals. Spending on pharmaceuticals has grown faster than that for other health spending components, however, with annual growth . . . [Full Text of this Article] |
Cosmetic Psychotropics For The Worried Well?
|
|---|
Appropriate use.Available evidence.|
Quality And Value Of Antidepressant Treatment
|
|---|
|
Summary, Implications, And Policy Options
|
|---|

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Schoenbaum, K. Kelleher, J. R. Lave, S. Green, D. Keyser, and H. Pincus
Exploratory Evidence on the Market for Effective Depression Care in Pittsburgh
Psychiatr Serv,
April 1, 2004;
55(4):
392 - 395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Iglehart
The Dilemma of Medicaid
N. Engl. J. Med.,
May 22, 2003;
348(21):
2140 - 2148.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Loosbrock, M. E. Tomlin, R. L. Robinson, R. L. Obenchain, and T. W. Croghan
Appropriateness of Prescribing Practices for Serotonergic Antidepressants
Psychiatr Serv,
February 1, 2002;
53(2):
179 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|